Is there any conceivable justification for a company that had nothing to do with the R&D, taking over a company, and then overnight raising the price so that it is, let's be fair, out of reach for patients and even some hospitals?
Questioning the justification for a drastic price increase on Daraprim after its acquisition.
Share
More from Eleanor Holmes Norton
This bill would establish a commonsense process to ensure that qualified nominees are not indefinitely delayed by Senate inaction.
The policies being proposed by the former President are inflationary and would cost everyday Americans thousands of dollars each year.
H.R. 8505 would provide FMCSA with better tools to root out unscrupulous actors, which are also harmful to consumers and highway safety.
Other voices in this conversation
